Literature DB >> 16597360

Significant and prolonged antisense effect of a multifunctional envelope-type nano device encapsulating antisense oligodeoxynucleotide.

Yoshio Nakamura1, Kentaro Kogure, Yuma Yamada, Shiroh Futaki, Hideyoshi Harashima.   

Abstract

A multifunctional envelope-type nano device (MEND) was developed for use as an efficient non-viral system for the delivery of plasmid DNA (pDNA) using octaarginine (R8) as an internalizing ligand. Three types of R8-MENDs were prepared, co-encapsulating luciferase-encoding pDNA and anti-luciferase oligodeoxynucleotide (ODN) condensed by three polycations, stearyl octaarginine (STRR8), poly-L-lysine (PLL) and protamine, and the antisense effects of the ODN-encapsulated R8-MENDs (ODN-MEND) were analysed in-vitro. The ODN-MEND packaged using protamine as a condenser showed a 90% antisense effect 16 h after the transfection, and a persistent antisense effect of over 75% for up to 48 h, which was much more effective than that of LipofectAmine2000. On the other hand, the ODN-MENDs prepared using PLL and STR-R8 as condensers did not show any significant inhibition of luciferase activity. Although there was no specific relation between the physicochemical characteristics of the ODN-MENDs and their antisense effect, the pattern of the antisense effect among the ODN-MENDs was similar to that of the silencing effect of R8-MEND encapsulating plasmid DNA encoding siRNA. These results suggest that R8-MENDs are able to deliver encapsulated DNA to the cytosol as well as to the nucleus, and that protamine can also function as an efficient decondenser, not only in the nucleus but also in the cytosol. In conclusion, we successfully developed an ODN-MEND with a high antisense effect using protamine as a DNA condensing as well as a decondensing agent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16597360     DOI: 10.1211/jpp.58.4.0002

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  9 in total

Review 1.  Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment.

Authors:  Ayman El-Sayed; Shiroh Futaki; Hideyoshi Harashima
Journal:  AAPS J       Date:  2009-01-06       Impact factor: 4.009

Review 2.  Composite nanoparticles for gene delivery.

Authors:  Yuhua Wang; Leaf Huang
Journal:  Adv Genet       Date:  2014       Impact factor: 1.944

Review 3.  Cell-penetrating peptides as versatile vehicles for oligonucleotide delivery.

Authors:  Helerin Margus; Kärt Padari; Margus Pooga
Journal:  Mol Ther       Date:  2012-01-10       Impact factor: 11.454

4.  Dual function MITO-Porter, a nano carrier integrating both efficient cytoplasmic delivery and mitochondrial macromolecule delivery.

Authors:  Yuma Yamada; Ryo Furukawa; Yukari Yasuzaki; Hideyoshi Harashima
Journal:  Mol Ther       Date:  2011-06-21       Impact factor: 11.454

Review 5.  Strategies on the nuclear-targeted delivery of genes.

Authors:  Jing Yao; Ying Fan; Yuanke Li; Leaf Huang
Journal:  J Drug Target       Date:  2013-08-22       Impact factor: 5.121

6.  Fabrication of functionalized double-lamellar multifunctional envelope-type nanodevices using a microfluidic chip with a chaotic mixer array.

Authors:  Katsuma Kitazoe; Yeon-Su Park; Noritada Kaji; Yukihiro Okamoto; Manabu Tokeshi; Kentaro Kogure; Hideyoshi Harashima; Yoshinobu Baba
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

Review 7.  Multiple cues on the physiochemical, mesenchymal, and intracellular trafficking interactions with nanocarriers to maximize tumor target efficiency.

Authors:  Sang-Woo Kim; Dongwoo Khang
Journal:  Int J Nanomedicine       Date:  2015-06-17

8.  Recent developments in peptide-based nucleic acid delivery.

Authors:  Sandra Veldhoen; Sandra D Laufer; Tobias Restle
Journal:  Int J Mol Sci       Date:  2008-07-16       Impact factor: 6.208

9.  Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA.

Authors:  Peter Järver; Thibault Coursindel; Samir El Andaloussi; Caroline Godfrey; Matthew Ja Wood; Michael J Gait
Journal:  Mol Ther Nucleic Acids       Date:  2012-06-12       Impact factor: 10.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.